Fig. 2From: ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)De-escalation/escalation strategy in ctDNA negative group in the ctDNA-guided armBack to article page